 UNA RYAN, OBE, PhD, DSc |
 JASON ROLLAND, PhD |
 SHAILENDRA KUMAR, M.Phil, PhD |
 MATTHEW STEWART, PhD |
 CHARLES MACE, PhD |
 PATRICK BEATTIE |
 PAUL SHAW, MS |
 SIDHARTHA JAIN, MS |
 BENJAMIN WHITESIDES |
UNA RYAN, OBE, PhD, DSc CEO, Diagnostics For AllDr. Ryan is the CEO of Diagnostics For All. She has an extensive background in leading biotech companies and was formerly the President and CEO of AVANT Immunotherapeutics, Inc., a publicly traded biopharmaceutical company developing vaccines. Dr. Ryan is also Research Professor of Medicine at Boston University School of Medicine and serves on its Board of Visitors. She serves on a number of boards including Waltham Technologies Inc., AMRI Global, IQuum, the Business Advisory Board of BIO Ventures for Global Health, the Scientific Advisory Board of Genocea, Inc. She is past Chair of the Massachusetts Biotechnology Council, served on its Board (1996-2008), as well as the Board of the Biotechnology Industry Organization. She is a member of the Massachusetts Life Sciences Collaborative Leadership Council, and the Climate Change and Green Energy Council. Dr. Ryan holds a Ph.D. in Cellular and Molecular Biology from Cambridge University and BS degrees in Zoology, Microbiology and Chemistry from Bristol University. She received an Honorary Doctor of Science Degree from Bristol University in 2009. She was a Howard Hughes Investigator, NIH MERIT Awardee and an Established Investigator of the American Heart Association. In 2007, she received the Albert Einstein Award for outstanding achievement in the life sciences and was the recipient of the Cartier Women’s Initiative Award in 2009. In 2002 Her Majesty Queen Elizabeth II awarded her the Order of the British Empire (OBE) for her services to the research, development and promotion of biotechnology. She has written over 500 original papers and 11 books. Back to Top »
JASON ROLLAND, PhD Director of Research Dr. Rolland joined Diagnostics For All in 2010 as the Director of Research. He has a broad background in polymer chemistry and nanofabrication. He was formerly Director of Research and Development at Liquidia Technologies, a startup in RTP, NC which he co-founded in 2004. Dr. Rolland is a co-inventor of the PRINT® platform, a novel technique for the fabrication of engineered nanoparticles with controlled size, shape, and chemistry. His research was awarded the National Starch & Chemical Company Award for Outstanding Graduate Research in Polymer Chemistry (2007) and has been featured in Science magazine and Chemical and Engineering News. He has led numerous multi-disciplinary projects including the fabrication of solvent-compatible microfluidics for chemical synthesis, large-scale reel to reel fabrication of nanoparticles, and the development of novel vectors for siRNA delivery in collaboration with Abbott Laboratories. Dr. Rolland has a B.S. in Chemistry from Virginia Tech and a Ph.D. in Polymer Chemistry from the University of North Carolina at Chapel Hill. Back to Top »
SHAILENDRA KUMAR, M.Phil, PhD Director of Product Development Dr. Kumar joined Diagnostics For All in March, 2010 as the Director of Product Development. Dr. Kumar has over 20 years of biotechnology and academic experience from discovery through product launch with a primary technical expertise in immunodiagnostics, biochemistry, biomarkers and proteomics. Most recently, Dr. Kumar served as Director of Research and Development for Chembio Diagnostics, Inc. where he has overseen a team involved in developing immunodiagnostic tests for infectious diseases including Syphilis, HIV HCV and Leishmania. Before joining Chembio, Dr. Kumar served as Senior Scientific Manager for Matritech, Inc. where he led the R&D team that took cancer biomarkers from discovery to clinical trials. Over his stay at Matritech, Dr. Kumar also directed the in-house development of lateral flow immunodiagnostic test for bladder cancer.
Dr. Kumar began his career in diagnostic industries in India (Ranbaxy laboratories and Mass Diagnostics), where he served as Scientist and Senior Scientific Manager. While working at these companies, he developed multiple immuno-diagnostic and biochemical diagnostic tests. After moving to USA, Dr. Kumar joined a Research group at Dana-Farber Cancer Institute (Harvard Medical School) and VA Medical Center (Harvard University) as an Instructor and worked in the area of signal transduction, apoptosis and DNA damage. He has published over 25 scientific papers in professional journals. Dr. Kumar holds a MS in biochemistry from the Aligarh University, India; an M. Phil in biochemistry; and a PhD in biochemistry from the Aligarh University and Central Drug Research Institute, India. Back to Top »
MATTHEW STEWART, PhD Senior Scientist Dr. Stewart joined Diagnostics For All in April, 2011 as a Senior Scientist. Prior to DFA, Matthew worked at Nano Terra, Inc. as a Senior Scientist developing innovative surface science and surface engineering solutions to scientific challenges in the government and commercial sectors. He has industry and academic experience using conventional and unconventional nano- and micro-scale fabrication techniques to develop functional coatings, microfluidic devices, and optical sensors. Matthew has authored multiple winning research proposals for government and commercial programs, and is co-inventor on multiple patent applications -- with one issued patent on multispectral nanostructured plasmonic sensors. He has published one book chapter and 10 articles in peer-reviewed journals - including two reviews - on nanoscale patterning techniques and optical sensors. In addition, Matthew serves as a reviewer for both Langmuir and Analytical Chemistry. Dr. Stewart has an ACS certified B.S. in Chemistry from Wittenberg University and a Ph.D. in Chemistry (analytical focus) from the University of Illinois at Urbana-Champaign. Back to Top »
CHARLES MACE, PhD Senior Scientist Dr. Mace joined Diagnostics For All in August 2011 as a Senior Scientist. Charles has a broad background in surface chemistry, bioanalytical chemistry, and biophysics, and he has more than eight years of experience in developing immunoassays using labeled and label-free approaches. Prior to DFA, Charles was a postdoctoral fellow in the Whitesides laboratory at Harvard University. His research included developing new approaches to density-based separations and analysis (magnetic levitation and multiphase polymer systems) and characterizing the sensitivity of the paper diagnostics platform. As a graduate assistant in the Miller laboratory at the University of Rochester, Charles developed an optical biosensor platform, arrayed imaging reflectometry, which employed adaptive thin-film techniques to generate functional surfaces capable of monitoring the immune response to vaccines and differentiating pathogenic and non-pathogenic E. coli. Dr. Mace has a B.S. in Physics from Le Moyne College and an M.S. and Ph.D. in Biophysics from the University of Rochester. He has published twelve articles in peer-reviewed journals, is an author of one book chapter, and is a co-inventor on nine patent applications. Back to Top »
PATRICK BEATTIE Global Health Operations Mr. Beattie brings a wealth of experience working on the ground in the regions DFA is targeting for product launch. Prior to DFA, he joined the US Peace Corps as a math and science teacher and served for a total of 3 years in The Gambia and Guinea – parts of Anglophone and Francophone West Africa, respectively. While there, he lived as the only westerner in remote villages and taught math and science, implemented education and health related projects, and fostered increased cultural understanding between his hosts and Americans. In addition to French, he has learned a variety of local languages native to West Africa and is fluent in Mandinka, the primary local dialect of The Gambia. He has also traveled extensively throughout West and North Africa, from Cameroon to Morocco and most countries in between. Mr. Beattie received a B.S.E. degree magna cum laude in Chemical Engineering from Princeton University, specializing in nano-particles for drug delivery and was awarded the Ernest F. Johnson Distinguished Service Award. Back to Top »
PAUL SHAW, MSResearch ScientistMr. Shaw joined Diagnostics For All in August 2011. He brings with him 15 years of experience in the biotechnology industry, including roles in the development of FDA approved in-vitro diagnostics tests and protein therapeutics. He has worked on projects covering diverse disease areas, including infectious disease, cardiovascular disease, diabetes, oncology, inflammation and neurological disorders. Prior to joining DFA, he worked at Millennium, The Takeda Oncology Company, where he was part of a small team responsible for analytical development activities in support of the Biologics Process Development group. Before Millennium, Paul was employed at Genzyme Diagnostics, where he co-developed multiple IVD tests in formats ranging from ELISA to lateral flow to those for central lab instrumentation. In addition to assay development, he was also responsible for the implementation of the group’s cell culture and protein purification capabilities for the production of monoclonal antibodies, as well the transfer of these processes to production facilities in the U.S. and the United Kingdom. In the time between his roles at Millennium and Genzyme, Paul started and ran a successful Biomedical Information Consulting business. He holds a B.S. degree in Biology with a concentration in Biotechnology from the University of Massachusetts, and an M.S. in General Biomedical Science from Northeastern University. Back to Top »
SIDHARTHA JAIN, MSResearch ScientistSidhartha joined Diagnostics For All in May 2010 as a Research Scientist. Prior to joining DFA, Sidhartha worked as a volunteer in the Cytology Lab at Beth Israel Deaconess Medical Center, Boston, MA. Sidhartha has a M.S. in Biomedical Engineering from Drexel University and a B.S. in Biomedical
Engineering (Specializing in Mechanical Engineering) from Louisiana Tech University. Having led his senior design project, “Regeneration of Temporo-mandibular Joint Fibro-Cartilage Using Electrospun Polymer Scaffolds”, Sidhartha was awarded memberships to Alpha Eta Mu Beta (AEMB), Biomedical Engineering Honors Society and Tau Beta Pie, Engineering Honors Society at Louisiana Tech University. Back to Top »
BENJAMIN WHITESIDES Executive AssistantBio Forthcoming Back to Top »
